Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
INS-1E |
Rat pancreatic tumor (insulinoma) derived ß cell line | Rat | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | J. Wright et al., J. Biol. Chem., Oct 2013; 288: 31010 - 31018 | Link | |||
INS-1E |
Rat pancreatic tumor (insulinoma) derived ß cell line | Rat | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | J. J. Wright, PhD Thesis, 2015, University of Michigan | Link | |||
INS-1 832/13 |
Rat pancreatic tumor (insulinoma) derived ß cell line | Rat | digestive organs | cell line | suspension | plasmid | Metafectene | publication | J. Wu et al., ACS Chem. Neurosci., 2013, 4: 963−972, doi.org/10.1021/cn400012b | Link | |||
INS-1 832/13 |
Rat pancreatic tumor (insulinoma) derived ß cell line | Rat | digestive organs | cell line | suspension | plasmid | K2 Transfection System | publication | A. Aslamy et al., Diabetes, 2018, 67(7): 1332‐1344, doi.org/10.2337/db17‐1352 | ||||
INS-1 832/13 |
Rat pancreatic tumor (insulinoma) derived ß cell line | Rat | digestive organs | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | J. Wu, PhD Thesis, 2014, University of Alberta | Link | ||
INS-1 |
Rat insulin secreting beta cell derived line | Rat | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | T. G. Deering et al., Diabetes, Jan 2009; 58: 185 - 193 | Link | |||
INS-1 |
Rat insulin secreting beta cell derived line | Rat | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | T. Kono et al., Mol Endocrinol, 2012, 26(2): 257-271. doi: 10.1210/me.2011-1181 | Link | |||
INS-1 |
Rat insulin secreting beta cell derived line | Rat | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | D. Li et al., ACS Chem. Biol., 2015, 10: 1054−1063; DOI: 10.1021/cb5007536 | ||||
INS-1 |
Rat insulin secreting beta cell derived line | Rat | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | R. G. Mirmira et al., 2012, US 2012/0196918 | Link | |||
IMR-90 |
Human primary lung fibroblasts | ATCC CCL-186 | Human | respiratory system | primary cell | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene | publication | A. M. Szekely et al., Mol. Cell. Biol., Dec 2005; 25: 10492 - 10506 | Link | |
IMR-32 |
Human brain neuroblastoma cells | ATCC CCL-127 | Human | brain | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
IMR-32 |
Human brain neuroblastoma cells | ATCC CCL-127 | Human | brain | unknown | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
IHKE1 |
Human kidney epithelial cells | Human | urinary system | unknown | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
IGR-37 |
Human cutaneous melanoma cell line | Human | skin | cell line | adherent | plasmid | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | ||||
iDC |
Human immature dentritic cells | Human | immune system | primary cell | plasmid | Metafectene | publication | Z. K. Nazarkina et al., Mol. Biology, 2018, 52(2): 222–231, DOI: 10.1134/S0026893317050132 | |||||
IC-21 |
Mouse peritoneal macrophage cell line | ATCC TIB-186 | Mouse | unknown | cell line | adherent | plasmid | Metafectene | publication | L. K. Hanson et al., J. Virol., Aug 2009; 83: 7449 - 7456 | Link | ||
HW3-5 |
Mouse hippocampal cell line | Mouse | brain | cell line | adherent | plasmid | Metafectene | publication | T. Barz et al., Cancer Res., Dec 2006; 66: 11975 - 11982 | Link | |||
hVSMC |
Human primary vascular smooth muscle cells | Human | vasculature | primary cell | adherent | plasmid | stable transfection | Metafectene | publication | G. Weisinger et al., Exp. Cell Res., 2013, 319: 1586-1593, doi.org/10.1016/j.yexcr.2013.04.001 | |||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S.-W. Lee et al., Molecular Therapy, 2013, 21 (9): 1767–1777, doi:10.1038/mt.2013.146 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S. Bellou et al., Am J Physiol Cell Physiol, Dec 2009; 297: C1477 - C1489 | |||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S. Zografou et al., J. Cell Sci., Oct 2012; 125: 4780 - 4790 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | S. Thakker et al., Oncotarget, 2018, 9 (1): 1210-1228 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | N. Kostopoulou et al., J. Cell Sci., 2021, 134, jcs246892, doi:10.1242/jcs.246892 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | J. Yang et al., Oncology Reports, 2015, 34: 2745-2751; DOI: 10.3892/or.2015.4223 | Link | ||
HuP-T3 |
Human pancreatic adenocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | J. Pahle, Dissertation, 2017, Humboldt-Universität zu Berlin | Link |